Press-release for stocks

Prices are updated after-hours

rare

save search

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-04-19 (Crawled : 20:00) - globenewswire.com
RARE | News F | $42.37 -2.33% -2.38% 680K

Health Technology

| Email alert Add to watchlist
nasdaq grant

Ultragenyx Announces Positive Interim Phase 1/2 Data in Patients with Angelman Syndrome After Treatment with GTX-102
Published: 2024-04-15 (Crawled : 11:00) - globenewswire.com
RARE | News F | $42.37 -2.33% -2.38% 680K

Health Technology

| -15.13% | O: -10.79% H: 0.0% C: -3.75%
gtx-102 positive treatment

Ultragenyx Announces Update to Conference Call Timing to Discuss New Data from GTX-102 in Patients with Angelman Syndrome
Published: 2024-04-12 (Crawled : 20:00) - globenewswire.com
RARE | News F | $42.37 -2.33% -2.38% 680K

Health Technology

| Email alert Add to watchlist
gtx-102 conference update

Ultragenyx Announces Upcoming Data Presentations at American Academy of Neurology (AAN) 2024 Annual Meeting
Published: 2024-04-12 (Crawled : 12:00) - globenewswire.com
RARE | News F | $42.37 -2.33% -2.38% 680K

Health Technology

| -18.75% | O: -4.27% H: 0.0% C: 0.0%
meeting

Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics
Published: 2024-04-09 (Crawled : 13:00) - biospace.com/
CRL | $226.78 -0.34% 0.0% 410K

Commercial Services

| -11.04% | O: 0.93% H: 0.36% C: -0.05%
rare disease collaboration therapeutics therapy

Solid Biosciences Receives Rare Pediatric Disease Designation from the FDA for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003
Published: 2024-04-01 (Crawled : 12:00) - globenewswire.com
SLDB | $8.7 -6.05% -6.44% 110K

Health Technology

| -41.24% | O: -9.02% H: 0.0% C: -7.65%
sgt-003 fda rare candidate disease designation duchenne therapy

FDA Approves New Treatments for Two Rare Diseases
Published: 2024-03-27 (Crawled : 13:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -7.26% | O: -0.26% H: 0.0% C: 0.0%
PRGO | News | $30.8 2.87% -1.14% 1.2M

Health Technology

| 0.0% | O: 0.84% H: 1.48% C: 1.29%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -4.96% | O: 0.3% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M

Health Technology

| -2.86% | O: 1.48% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -5.89% | O: 1.06% H: 0.0% C: 0.0%
fda rare

Kiora Pharmaceuticals Reports 2023 Results; Continues to Advance Pipeline of Treatments for Rare Retinal Diseases
Published: 2024-03-25 (Crawled : 15:30) - biospace.com/
KPRX | $0.502 -1.57% -1.59% 49K

Manufacturing

| -18.33% | O: 0.32% H: 0.0% C: -3.46%
rare pipeline pharmaceuticals

Uranium Energy Corp Announces the Appointment of Brent Berg as Senior Vice-President, U.S. Operations
Published: 2024-03-25 (Crawled : 12:30) - prnewswire.com
REEMF | $0.1938 17.02% 34K

Mining, Quarrying, and Oil and ...

| 6.8% | O: -4.44% H: 9.35% C: 4.71%
UROY | $2.43 -4.33% -4.53% 1.9M

Mining, Quarrying, and Oil and ...

| 3.29% | O: 0.0% H: 4.12% C: -1.65%
energy uranium

Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the Treatment of Prader-Willi Syndrome
Published: 2024-03-25 (Crawled : 12:00) - globenewswire.com
TNXP | $0.159 1.27% 1.26% 1.1M

Health Technology

| -53.76% | O: 0.0% H: 0.03% C: -5.2%
tnx-2900 fda rare disease treatment pharmaceuticals designation

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-03-22 (Crawled : 20:00) - globenewswire.com
RARE | News F | $42.37 -2.33% -2.38% 680K

Health Technology

| Email alert Add to watchlist
nasdaq grant

Ramaco Resources, Inc. Announces Major Independent Rare Earth Elements Update From Weir International; New Shareholder Letter Released; Conference Call To Be Held March 27
Published: 2024-03-21 (Crawled : 21:00) - prnewswire.com
METC | $15.58 -0.45% -0.45% 460K

Energy Minerals

| -6.37% | O: 1.74% H: 0.89% C: -1.36%
rare conference update

Kazia Therapeutics licenses paxalisib to Sovargen for intractable seizures in rare central nervous system diseases
Published: 2024-03-21 (Crawled : 21:00) - biospace.com/
KZIA | $0.379 9.47% 8.65% 300K

Health Technology

| 36.2% | O: -6.81% H: 8.65% C: -2.23%
rare paxalisib system therapeutics

Lisata Therapeutics Announces U.S. FDA Rare Pediatric Disease Designation Granted to LSTA1 for the Treatment of Osteosarcoma
Published: 2024-03-21 (Crawled : 12:00) - globenewswire.com
LSTA | $2.85 -5.82% 2K

Manufacturing

| -12.62% | O: 0.32% H: 9.68% C: 8.06%
fda rare disease granted treatment designation therapeutics

Health Canada Accepts for Review New Drug Submission for Tofersen for Treatment of Rare, Genetic Form of ALS
Published: 2024-03-19 (Crawled : 12:30) - biospace.com/
IONS | $40.64 -0.42% -0.42% 850K

Health Technology

| -3.21% | O: -0.33% H: 1.89% C: 0.64%
drug health genetic als review treatment canada submission

FDA Approves First Gene Therapy for Rare Pediatric Disease
Published: 2024-03-18 (Crawled : 23:00) - biospace.com/
PRGO | News | $30.8 2.87% -1.14% 1.2M

Health Technology